| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. | Cell | 2003 | 4.33 |
| 2 | Emerging functions of BRCA2 in DNA recombination. | Trends Biochem Sci | 2004 | 1.55 |
| 3 | BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation. | Oncogene | 2003 | 1.30 |
| 4 | Cdk1 promotes kinetochore bi-orientation and regulates Cdc20 expression during recovery from spindle checkpoint arrest. | EMBO J | 2011 | 0.87 |
| 5 | Small-molecule inhibitors that target protein-protein interactions in the RAD51 family of recombinases. | ChemMedChem | 2014 | 0.84 |
| 6 | AURKA overexpression accompanies dysregulation of DNA-damage response genes in invasive urothelial cell carcinoma. | Cell Cycle | 2008 | 0.77 |
| 7 | Q&A: Ashok Venkitaraman on "undruggable" targets. Interview by Eric Bender. | Cancer Discov | 2013 | 0.75 |